136 related articles for article (PubMed ID: 2453919)
1. Ultrasonic evaluation of age-related human prostatic growth and development of benign prostatic hyperplasia.
Jakobsen H; Torp-Pedersen S; Juul N
Scand J Urol Nephrol Suppl; 1988; 107():26-31. PubMed ID: 2453919
[TBL] [Abstract][Full Text] [Related]
2. The effect of dutasteride on the peripheral and transition zones of the prostate and the value of the transition zone index in predicting treatment response.
Marks LS; Roehrborn CG; Wolford E; Wilson TH
J Urol; 2007 Apr; 177(4):1408-13. PubMed ID: 17382742
[TBL] [Abstract][Full Text] [Related]
3. The long-term influence of vasectomy on prostatic volume and morphology in man.
Jakobsen H; Torp-Pedersen S; Juul N; Hald T
Prostate; 1988; 13(1):57-67. PubMed ID: 2458585
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
[TBL] [Abstract][Full Text] [Related]
5. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
[TBL] [Abstract][Full Text] [Related]
6. Prostatic growth rate determined from MRI data: age-related longitudinal changes.
Williams AM; Simon I; Landis PK; Moser C; Christens-Barry W; Carter HB; Metter EJ; Partin AW
J Androl; 1999; 20(4):474-80. PubMed ID: 10452590
[TBL] [Abstract][Full Text] [Related]
7. Age-related changes in guinea pig prostatic stroma.
Horsfall DJ; Mayne K; Ricciardelli C; Rao M; Skinner JM; Henderson DW; Marshall VR; Tilley WD
Lab Invest; 1994 May; 70(5):753-63. PubMed ID: 8196369
[TBL] [Abstract][Full Text] [Related]
8. [PSA/volume ratio in prostatic disease in the elderly].
Bo M; Ventura M; Massaia M; Fabris F
Recenti Prog Med; 2001 Oct; 92(10):594-8. PubMed ID: 11695303
[TBL] [Abstract][Full Text] [Related]
9. Transrectal prostatic ultrasonography. Equipment, normal findings, benign hyperplasia and cancer.
Torp-Pedersen S; Juul N; Jakobsen H
Scand J Urol Nephrol Suppl; 1988; 107():19-25. PubMed ID: 2453918
[TBL] [Abstract][Full Text] [Related]
10. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
11. Relationship between serum testosterone and measures of benign prostatic hyperplasia in aging men.
Liu CC; Huang SP; Li WM; Wang CJ; Chou YH; Li CC; Huang CH; Wu WJ
Urology; 2007 Oct; 70(4):677-80. PubMed ID: 17991536
[TBL] [Abstract][Full Text] [Related]
12. Dutasteride improves objective and subjective disease measures in men with benign prostatic hyperplasia and modest or severe prostate enlargement.
Gittelman M; Ramsdell J; Young J; McNicholas T
J Urol; 2006 Sep; 176(3):1045-50; discussion 1050. PubMed ID: 16890688
[TBL] [Abstract][Full Text] [Related]
13. [The quotient of prostate-specific antigen and prostate volume. Improved differentiation between benign prostatic hyperplasia and locally circumscribed prostate cancer].
Semjonow A; Hamm M; Rathert P
Urologe A; 1993 May; 32(3):250-3. PubMed ID: 7685557
[TBL] [Abstract][Full Text] [Related]
14. Vascular resistance in the prostate evaluated by colour Doppler ultrasonography: is benign prostatic hyperplasia a vascular disease?
Berger AP; Horninger W; Bektic J; Pelzer A; Spranger R; Bartsch G; Frauscher F
BJU Int; 2006 Sep; 98(3):587-90. PubMed ID: 16796699
[TBL] [Abstract][Full Text] [Related]
15. Patients with a large prostate show a higher prevalence of androgenetic alopecia.
Chen W; Yang CC; Chen GY; Wu MC; Sheu HM; Tzai TS
Arch Dermatol Res; 2004 Nov; 296(6):245-9. PubMed ID: 15517324
[TBL] [Abstract][Full Text] [Related]
16. The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia.
Ozden C; Ozdal OL; Urgancioglu G; Koyuncu H; Gokkaya S; Memis A
Eur Urol; 2007 Jan; 51(1):199-203; discussion 204-6. PubMed ID: 16806666
[TBL] [Abstract][Full Text] [Related]
17. Prevention of benign prostatic hyperplasia disease.
Marks LS; Roehrborn CG; Andriole GL
J Urol; 2006 Oct; 176(4 Pt 1):1299-306. PubMed ID: 16952616
[TBL] [Abstract][Full Text] [Related]
18. Relative and total volume of histological components in benign prostatic hyperplasia: relationships between histological components and clinical findings.
Ishigooka M; Hayami S; Hashimoto T; Suzuki Y; Katoh T; Nakada T
Prostate; 1996 Aug; 29(2):77-82. PubMed ID: 8700803
[TBL] [Abstract][Full Text] [Related]
19. Is transition zone biopsy valuable in benign prostatic hyperplasia patients with serum prostate-specific antigen >10 ng/ml and prior negative peripheral zone biopsy?
Abdel-Khalek M; Sheir KZ; El-Baz M; Ibrahiem el-H
Scand J Urol Nephrol; 2005; 39(1):49-55. PubMed ID: 15764271
[TBL] [Abstract][Full Text] [Related]
20. Role of canine basal cells in prostatic post natal development, induction of hyperplasia, sex hormone-stimulated growth; and the ductal origin of carcinoma.
Leav I; Schelling KH; Adams JY; Merk FB; Alroy J
Prostate; 2001 May; 47(3):149-63. PubMed ID: 11351344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
